$25.91
+0.39 (+1.53%)
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Price Target
Analyst Price Target
+139.6% upside
Low Target
$37.88
Average Target
$62.07
High Target
$80.69
Current Price
$25.91
Current
$25.91
$25.91
Target
$62.07
$62.07
$37.88
$62.07 avg
$80.69
Scenario Analysis
Bear Case
$37.88
46.2%
Low target
Base Case
$62.07
+139.6%
Avg target
Bull Case
$80.69
+211.4%
High target
Risk/Reward
4.6x
Highly favorable
Price in Context
52-Week High
$38.26
-32.3% from high
52-Week Low
$15.60
+66.1% from low
50-Day SMA
$28.48
-9.0% vs SMA
200-Day SMA
$22.69
+14.2% vs SMA
RSI (14)
44.0
Neutral
Target vs 52W High
$62.07
+62.2% vs high
Next Earnings Report
Aug 11, 2026
2d
until earnings
EPS Est: $-1.13
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |